AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2021
Dec 14, 2021
33483_dirs_2021-12-14_07d9947c-1a82-4e2b-bc90-9606ea52ccd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2021-12-10
Reporting Person: Kishimoto Takashi Kei (Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-10 | Common Stock | S | 4370 | $2.9869 | Disposed | 199769 | Direct |
Footnotes
F1: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
F2: The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $3.0201. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.